Table 2.
Anticoagulation Therapy Immediately Before Surgery
| Drugs, n (%) | All Patients, n=168 |
|---|---|
| Single drug | |
| Aspirin | 17 (10.1) |
| Heparin | 19 (11.3) |
| Newer oral anticoagulants | 5 (2.9) |
| Combination of drugs | |
| Aspirin+newer oral anticoagulants | 2 (1.2) |
| Aspirin+glycoprotein IIb/IIIa inhibitors | 3 (1.8) |
| Aspirin+P2Y12 inhibitors | 39 (23.2) |
| Aspirin+heparin | 39 (23.2) |
| Aspirin+glycoprotein IIb/IIIa inhibitors+P2Y12 inhibitors | 7 (4.2) |
| Aspirin+glycoprotein IIb/IIIa inhibitors+P2Y12 inhibitors+heparin | 7 (4.2) |
| Aspirin+P2Y12 inhibitors+heparin | 21 (12.5) |
| Aspirin+glycoprotein IIb/IIIa inhibitors+heparin | 4 (2.4) |
| Glycoprotein IIb/IIIa inhibitors+heparin | 4 (2.4) |
| No anticoagulation | 1 (0.6) |